2026-05-28T20:38:22Zhttps://riuma.uma.es/rest/oai/request

oai:riuma.uma.es:10630/257222026-02-03T12:19:36Zcom_10630_2254col_10630_37959

00925njm 22002777a 4500 dc Burgos-Molina, Antonio Manuel author Alamilla Presuel, Juan Carlos author González Vidal, Alejandro author Ruiz-Gómez, Miguel José author 2022 Cells need energy to survive, therefore, they increase the different pathways available to obtain it. This suggests that the cell, due to the cytotoxicity of bleomycin, increases the routes to obtain energy. For this reason, GPM1 could be a good candidate as bleomycin chemo-resistance biomarker. Knowing of the homologous gene in humans facilitates more studies of the expression of this protein in tumors. https://hdl.handle.net/10630/25722 Metabolismo - Congresos Metabolism is altered in the process of drug resistance acquisition